From Prompt to Phase III: Biomarker Discovery for Bispecific Antibodies in DLBCL
K-Dense Web autonomously integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecific antibodies in B-cell lymphoma.